Mental Health DailyResearch. Evidence. Perspective.Published research on brintellix.
Trintellix (Vortioxetine hydrobromide), formerly sold under the name Brintellix, is an antidepressant that was jointly developed by the pharmaceutical companies Lundbeck and Takeda. In 2013,…
Read articleBrintellix (Vortioxetine) is an atypical antidepressant manufactured by Lundbeck and Takeda. It was approved by the FDA in 2013 for the treatment of major depressive disorder, but failed to …
Read articleBrintellix (Vortioxetine) is considered an atypical antidepressant that was co-developed by pharmaceutical companies Lundbeck and Takeda. Most consider Brintellix to be a new antidepressant …
Read articleBrintellix (Vortioxetine) is a drug that was approved by the FDA in 2013 to treat major depression. It is regarded as an atypical antidepressant, meaning that it’s mechanisms of action are u…
Read articleWhen a new antidepressant drug is released, everyone wants to be the first to try it. In most cases, people seem to always believe that newer will equal better in terms of depression relief.…
Read articleAtypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: S…
Read article